The estimated Net Worth of Stuart Essig is at least $103 Milión dollars as of 23 May 2024. Stuart Essig owns over 52,641 units of Integra Lifesciences Corp stock worth over $8,587,427 and over the last 22 years he sold IART stock worth over $94,139,198. In addition, he makes $347,533 as Independent Chairman of the Board at Integra Lifesciences Corp.
Sign up
Stuart Essig IART stock SEC Form 4 insiders trading
Stuart has made over 78 trades of the Integra Lifesciences Corp stock since 2003, according to the Form 4 filled with the SEC. Most recently he bought 52,641 units of IART stock worth $1,499,742 on 23 May 2024.
The largest trade he's ever made was exercising 1,665,998 units of Integra Lifesciences Corp stock on 11 December 2012 worth over $29,321,565. On average, Stuart trades about 45,933 units every 40 days since 2003. As of 23 May 2024 he still owns at least 487,922 units of Integra Lifesciences Corp stock.
You can see the complete history of Stuart Essig stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stuart Essig biography
Dr. Stuart M. Essig Ph.D. serves as Independent Chairman of the Board of the Company. He has been our Chairman since January 2012 and a director since he joined Integra in 1997. He served as our Chief Executive Officer from 1997 through 2012 and our President from 1997 until 2010. Prior to joining the Company, he acted as the managing director in mergers and acquisitions for the medical technology practice at Goldman, Sachs & Co. He currently serves as managing director of Prettybrook Partners LLC. Dr. Essig serves on the board of directors of IDEXX Laboratories, SeaSpine Holdings Corporation, Availity LLC, and as chairman of the board of directors of Breg, Inc. He previously served on the board of directors of St. Jude Medical Corporation, Owens & Minor Inc., Zimmer Holdings, Inc., and Vital Signs. Dr. Essig has also served on the executive committee, nominating and governance committee and as treasurer of ADVAMED. He is a founding investor member of Tigerlabs, a Princeton-based business accelerator. He is a Venture Partner at Wellington Partners Advisory AG and serves as a senior advisor to TowerBrook Capital Partners and Water Street Healthcare Partners. Inc. He is also involved in several non-profit charitable organizations and has, from time to time, served on the boards of such organizations. Dr. Essig also serves on the Leadership Council, School of Engineering and Applied Sciences, Princeton University, and as a member of the Compensation Committee Chair Advisory Council of the National Association of Corporate Directors (NACD). Dr. Essig received an A.B. degree, and graduated with magna cum laude honors, from the Woodrow Wilson School of Public and International Affairs at Princeton University and an M.B.A. and Ph.D. in Financial Economics from the University of Chicago, Graduate School of Business.
What is the salary of Stuart Essig?
As the Independent Chairman of the Board of Integra Lifesciences Corp, the total compensation of Stuart Essig at Integra Lifesciences Corp is $347,533. There are 8 executives at Integra Lifesciences Corp getting paid more, with Peter Arduini having the highest compensation of $7,859,420.
How old is Stuart Essig?
Stuart Essig is 58, he's been the Independent Chairman of the Board of Integra Lifesciences Corp since 2012. There are 9 older and 12 younger executives at Integra Lifesciences Corp. The oldest executive at Integra Lifesciences Holdings Corp is Dr. Richard E. Caruso, 78, who is the Founder and Chairman Emeritus.
What's Stuart Essig's mailing address?
Stuart's mailing address filed with the SEC is 512 WEST MLK JR. BLVD #320, , AUSTIN, TX, 78701.
Insiders trading at Integra Lifesciences Corp
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig a George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
What does Integra Lifesciences Corp do?
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
What does Integra Lifesciences Corp's logo look like?
Complete history of Stuart Essig stock trades at Dynatronics, Idexx Laboratories, Integra Lifesciences Corp, Orthofix Medical Inc, SeaSpine Corp a Owens & Minor
Integra Lifesciences Corp executives and stock owners
Integra Lifesciences Corp executives and other stock owners filed with the SEC include:
-
Peter Arduini,
President, Chief Executive Officer, Director -
Glenn Coleman,
Chief Operating Officer, Executive Vice President -
Carrie Anderson,
Chief Financial Officer, Executive Vice President -
Eric Schwartz,
Executive Vice President, Chief Legal Officer, Secretary -
Robert Davis,
Executive Vice President, President - Orthopedics and Tissue Technologies -
Glenn G. Coleman,
Exec. VP & COO -
Carrie L. Anderson,
Exec. VP, CFO & Treasurer -
Robert T. Davis Jr.,
Exec. VP and Pres of Orthopedics & Tissue Technologies -
Stuart Essig,
Independent Chairman of the Board -
Rhonda Ballintyn,
Independent Director -
Barbara Hill,
Independent Presiding Director -
Christian Schade,
Independent Director -
Donald Morel,
Independent Director -
Lloyd Howell,
Independent Director -
Keith Bradley,
Independent Director -
Raymond Murphy,
Independent Director -
Michael Beaulieu,
IR Contact Officer -
Jeffrey Mosebrook,
Senior Vice President, Principal Accounting Officer -
Michael McBreen,
Executive Vice President and President - Codman Specialty Surgical -
Lisa Evoli,
Executive Vice President, Chief Human Resources Officer -
Eric Ian Schwartz,
Exec. VP, Chief Legal Officer & Sec. -
William Compton,
Chief Information Officer & Sr. VP -
Dr. Kenneth E. Burhop Ph.D.,
Corp. VP & Chief Scientific Officer -
Jeffrey Mosebrook,
Sr. VP, Principal Accounting Officer & Corp. Controller -
Dr. Richard E. Caruso,
Founder and Chairman Emeritus -
Jan De Witte,
Pres, CEO & Director -
James M Sullivan,
Director -
John Mooradian,
Corp VP, Global Ops & Supp Chn -
Judith Ogrady,
CorpVP,Global Reg.Affairs -
Kenneth Burhop,
CORPVP,CHIEFSCIENTIFIC OFFICER -
Mark A Augusti,
CVP,PRES-ORTHO & TISSUE TECH -
Richard D. Gorelick,
Corp VP, Gen Counsel & Sec -
Harvinder Singh,
EVP & PRESIDENT, INTERNATIONAL -
Chantal Veillon Berteloot,
EVP & CHRO -
Richard E Caruso,
10% owner -
Witte Jan De,
President & CEO -
Joseph Vinhais,
Corp VP,Quality&Transformation -
George Soros,
10% owner -
David B Holtz,
Sr. VP, Finance -
David C Auth,
Director -
Don R Nociolo,
Senior V.P., Operations -
Michael Piershbacher,
Senior VP, Research & Dev. -
Maureen B Bellantoni,
Exec V.P./CFO -
Neal Moszkowski,
Director -
Anne Vanlent,
Director -
Thomas J Jr Baltimore,
Director -
Daniel L. Reuvers,
CVP,PRES - CODMAN SPC SURGICAL -
Deborah A Leonetti,
Senior VP, Marketing -
Padma Thiruvengadam,
Corp VP, Chief HR Officer -
Robert D Paltridge,
Sr. VP, Global Sales -
Gerard S Carlozzi,
Exec. V.P., COO -
Brian Larkin,
Corp VP, Pres.Gbl Spine &Ortho -
John B Iii Henneman,
Exec. V.P., CAO, & Secretary -
Jerry E Corbin,
VP & Corporate Controller -
St Partnership, L.P. Tru,
10% owner -
Jeffrey A Graves,
Director -
Renee Wonlai Lo,
Director -
Lea Daniels Knight,
EVP & CHIEF FINANCIAL OFFICER